which are essentially good
they are in a pickle with Cornell/Yorkville which is dumping shares on the market that are connected with liquidated damages due to them when TNSX failed to get a $1.6mil convertible registered that was arranged almost 2 1/2 yrs ago.
the company's revs come from a Brazilian subsidiary called Medlink which they agreed to sell for something in the neighborhood of .18/share. Outstanding debts of the parent probably reduce this figure by .06 or .06/share
Supposedly, the company's lawyers are trying to figure out how to throw the Cornell monkey off their back. Until they do so, Cornell is getting something like 1.5mil shares/mo. that they dump immediately.
If you don't know the story you are playing with fire.. Congrats on your windfall profits... they could expand exponentially if they get a restraining order or some relief from the courts, or get diluted further.
I am looking forward to a new calculation of shares outstanding after the selling that happened midmonth to late month almost every month this year. The stock was trading above .05 before this mess:
if you don't do any DD, you are just gambling...
check out the figures in this post:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=29275011
you can see that the more cornell drives the price down the more shares they receive each month for fewer shares of their preferred stock. this is a classic death spiral in operation
this vulture funder is playing hardball. maybe they think they can gain control of an empty shell... i sure hope not. i have 100s of thousands of shares with an average cost just under .10 so am not a happy camper.
if they find a way to pay off Cornell the shares will really fly...if their shares O/S haven't ballooned too far.
it's interesting that their relationship with Cornell was never testy until they got a deal arranged, even though they'd been in default for some time.
I only wish TNSX management had conferred with Cornell BEFORE they entered an MOU with acquirers. Had this funder been involved on the front end, I'd bet they wouldn't be in this mess.
The original deal was for the entire subsidiary, their major asset and would have required shareholder approval. when it became obvious that Cornell wouldn't sign off, they rejiggered the deal for just under 50% of the subsidiary, so that shareholder approval via proxy isn't necessary.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM